ATUL BUTTE

M.D., Ph.D., Director, Institute for Computational Health Sciences, UCSF

Atul Butte, MD, PhD is the new Director of the new Institute of Computational Health Sciences (ICHS) at the University of California, San Francisco, and a Professor of Pediatrics. Dr. Butte trained in Computer Science at Brown University, worked as a software engineer at Apple and Microsoft, received his MD at Brown University, trained in Pediatrics and Pediatric Endocrinology at Children's Hospital Boston, then received his PhD from Harvard Medical School and MIT. Dr. Butte has authored nearly 200 publications, with research repeatedly featured in Wired Magazine, the New York Times, and the Wall Street Journal.  In 2013, Dr. Butte was recognized by the White House as an Open Science Champion of Change for promoting science through publicly available data.  Dr. Butte is also a founder of three investor-backed data-driven companies: Personalis, providing clinical interpretation of whole genome sequences, Carmenta (acquired by Progenity), discovering diagnostics for pregnancy complications, and NuMedii, finding new uses for drugs through open molecular data. Dr. Butte is also the principal investigator of ImmPort, the clinical and molecular data repository for the National Institute of Allergy and Infectious Diseases.

 

The Give and Take Between Government & Personalized Medicine

Personalized Medicine is the most promising way to create value for patients. It has the ultimate goal of targeted disease treatment if not disease prevention, with the patient up front and center, which requires policy changes so to encourage time and financial investment. We see a rise of new types of investments driven by President Obama’s Precision Medicine Initiative. Overall these developments require policy changes to improve health care quality and contain health care costs through transparency, efficiency, and innovation.

Web Analytics